StockData
Pulmatrix, Inc. logo

Pulmatrix, Inc. (PULM) stock

PULMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$1.37+0.04 (+3.01%)

Close on Nov 17, 2026Market cap $5.00MP/E –Yield –

Earnings

Pulmatrix's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Oct 15, 2026
Q3 FY2026 · estimated, before the open
Revenue, Q3 FY2025
$0
-100.0% on a year earlier
EPS, Q3 FY2025
-$0.24
-$0.71 a year earlier
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Pulmatrix's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q3 FY2026ended Sep 30, 2026Oct 15, 2026Expected––––
Q2 FY2026ended Jun 30, 2026Aug 13, 2026before the open–––Release
Q1 FY2026ended Mar 31, 2026May 15, 2026before the open–––Release
Q4 FY2025ended Dec 31, 2025Feb 26, 2026before the open–––Release
Q3 FY2025ended Sep 30, 2025Oct 16, 2025before the open$0-100.0%-$0.24Release
Q2 FY2025ended Jun 30, 2025Aug 6, 2025before the open$0-100.0%-$0.42Release
Q4 FY2024ended Dec 31, 2024Mar 21, 2025before the open–––Release
Q3 FY2024ended Sep 30, 2024Nov 8, 2024before the open$400.00K-77.8%-$0.71Release
Q2 FY2024ended Jun 30, 2024Aug 13, 2024before the open$1.60M-11.1%-$1.59Release
Q1 FY2024ended Mar 31, 2024May 10, 2024before the open$5.90M+293.3%$0.23Release
Q4 FY2023ended Dec 31, 2023Mar 28, 2024before the open–––Release
Q3 FY2023ended Sep 30, 2023Nov 9, 2023before the open$1.80M-5.3%-$1.03Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Pulmatrix has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Pulmatrix puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Pulmatrix filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Results
  4. Update
  5. Update
  6. Update
  7. Results
  8. Update
  9. Results
  10. Results
  11. Results
  12. Update
  13. Update
  14. Update
  15. Results

See a number that looks wrong?